Canine transmissible venereal sarcoma: distribution of T and B lymphocytes in blood, draining lymph nodes and tumours at different stages of growth. by Chandler, J. P. & Yang, T. J.
Br. J. Cancer (1981) 44, 514
CANINE TRANSMISSIBLE VENEREAL SARCOMA:
DISTRIBUTION OF T AND B LYMPHOCYTES IN BLOOD,
DRAINING LYMPH NODES AND TUMOURS AT
DIFFERENT STAGES OF GROWTH
J. P. CHANDLER AND T.-J. YANG
From the Department ofPathobiology, University ofConnecticut, Storrs, Connecticut 06268, U.S.A.
Received 22 February 1981 Accepte(d 23 April 1981
Summary.-The levels of T, B and null lymphocytes in the peripheral blood, draining
lymph nodes, and tumour masses at different growth stages in dogs transplanted
with canine transmissible venereal sarcoma (CTVS) were determined by immuno-
fluorescence techniques. The tumours were classified at excision into "progressor",
"steady state", and "regressor" stages of growth. The percentage of B cells in the
lymphocytes infiltrating into the progressively growing tumours (n =10, 37-3 +7.4° )
was significantly higher (P <0025) than that in regressing tumours (n=21, 26.1 +
1.9%). In contrast, the percentage of T cells in the lymphocytes infiltrating into the
regressing tumours (n=21, 61-2+2.6%) was significantly higher (P <0.005) than that
in the progressively growing tumours (n=10,34-0 +5.1%). The tumours at the steady-
state growth stage (n=9) had 50-8 +5.70 infiltrating T-cells, which was significantly
higher (P <0.005) than the progressors and lower (P <0-005) than the regressors. The
percentage of null cells of progressors (n=10, 260+6-9%) was significantly (P<
0.025) higher than in regressors (n=21, 13-5+2-9%). The draining lymph nodes of
progressor dogs (n=5) had significantly fewer (P<0-025) B cells (8-2 +2.3%) than in
normal (n=5, 16.1 +3.1%), regressors (n=12, 19.1 + 1.7%) and steady-state dogs
(n=5, 15-8 +2.6%). Although there was slightlymphopenia and fluctuation ofnull cells,
no significant differences in T- and B-lymphocyte levels were noted in the peripheral
blood of the tumour dogs (n=44) studied.
EVALUATION OF THE IMMUNE RESPONSE
elicited from neoplasms is of great impor-
tance in developing an effective immuno-
therapy for cancer patients through an
understanding of the host-tumour rela-
tionship. It involves the study of changes
in cell populations and functions of both
peripheral lymphoid cells (Silverman et al.,
1976; Lee et al., 1977; Domagala et al.,
1978; Garnes & Lala, 1978; Klein et al.,
1976; Klobusicka et al., 1978; Wood &
Neff, 1978; Svennevig et al., 1979; Santer
et al., 1980) and those infiltrating into
tumours (Edelson et al., 1975; Holden
et al., 1976; Vose et al., 1977a, b; Blazar &
Heppner, 1978; Domagala et al., 1978;
Svennevig et al., 1978; Konorza et al.,
1979; Thynne et al., 1979). These reports,
however, reflected the complex nature
of the host-tumour relationship and indi-
cated the need for a time-course study to
determine types, number, and function of
infiltrating lymphocytes and macrophages
(LM cells) from the time of tumour take
through rapid growth and spontaneous
regression.
It occurred to us that the canine trans-
missible venereal sarcoma (CTVS) would
be ideal for such a study. The tumour can
be transplanted into non-preconditioned
dogs, in which metastases can occur in
neonatally inoculated puppies, whereas
regression can occur in adults after a
period of rapid growth (Yang & Jones,
1973; Cohen, 1973, 1980). Furthermore, it
has previously been observed that the
percentage of viable LM cells out of total
viable cells in tumour-cell suspensionsT AND B CELLS IN CTVS STAGES
was inversely correlated with the log of
the tumour mass. This suggests that the
degree of LM-cell infiltration is a measure
of the host's immune response (Yang &
Jones, 1973). However, an estimate of the
surface area of the tumour, well perfused
with blood elements, showed that the LM
mass in a tumour was a function of its
surface area. Thus the inverse correlation
of the percentage of viable LM cells in a
viable tumour-cell suspension with the log
of the tumour mass might not necessarily
indicate that infiltrated LM cells were
active as immune effector cells (Yang et al.,
1976). For further assessment of this
phenomenon the infiltrating LM cells need
to be characterized.
In this communication we report B,
T, and null-cell levels in the peripheral
blood, draining lymph nodes, and tumour
masses at progressive, steady-state, and
regressive stages of growth. Function
studies will be presented in a subsequent
paper.
MATERIALS AND METHODS
Dogs-Forty-four dogs, 28 beagles (17 M,
11 F), 13 collie dogs (4 M, 9 F), and 3 female,
Labrador-collie crossbred dogs, ranging in
age from 3 months to 2 years, were used in
this study. An additional 13 beagles (8 M,
5 F) were used as normal controls. All dogs
were housed, fed, and received water ad
libitum at the Spring Hill Research Farm of
the University ofConnecticut.
Tumour transplantation.-A naturally oc-
curring CTVS was the source of the tumour
cells used for the laboratory transplantations.
At passage, single tumour-cell suspensions
were made by mincing the freshly collected
tumours in Hanks' balanced salt solution
(HBSS) containing penicillin and strepto-
mycin. Dogs were inoculated s.c. in the inter-
scapular region with 5-10 x 107 trypan-blue-
excluding tumour cells (Yang & Jones, 1973).
The experimental tumours used in this study
represented 14 transplantation generations
with 90% tumour take in immunologically
intact normal dogs. The growth pattern ofthe
tumour was monitored by weekly measure-
ments of the mass. Tumours were classified
at the time of excision into 3 categories:
Progressor-with a steadily increasing dimen-
sion up to the point of removal; Regressor-
which hadreached a maximum dimension and
was getting smaller at the time of excision;
and Steady State-which reached a particular
dimension and was neither increasing nor
decreasing in size at excision.
Isolation of lymphocytes.-Peripheral-blood
lymphocytes (PBL): Venous blood (10 ml)
was collected from tumour-bearing dogs into
heparinized tubes (preservative-free sodium
heparin, Fellows Medical Manufacturing Co.,
Oak Park, Mich.) before killing and ex-
sanguination. A 0-5ml aliquot of blood was
used for making smears and white and red
cell counts with the use of a Coulter Counter
(Model fn, Coulter Electronics, Inc., Hialeah,
Fla). The remainder of the blood was centri-
fuged at 210 g for 10 min at room tempera-
ture. The buffy coat was removed, suspended
to 6 ml with HBSS, and layered over a linear
sucrose polymer-diatrizoate density gradient,
as described by Muscoplat et al. (1977). The
resulting band of lymphocytes was removed
and washed in HBSS. Cytocentrifuge (Cyto-
spin, Model SCA-0031, Shandon Southern
Products, Ltd, Runcorn, Cheshire) smears
were made of the cell suspension for differen-
tial cell counts. Afterbloodhadbeencollected,
the dog was killed with T-61 (National
Laboratories Corp., Somerville, N.J.) and
exsanguinated by cardiac puncture to mini-
mize the tissue contamination by peripheral-
blood cells.
Lymph-node lymphocytes: The draining
(prescapular) lymph nodes were removed,
minced with scissors in HBSS, and the freed
cells were washed. Cytocentrifuge smears
were made ofthe cell suspension.
Lymphocytes from the tumour mass: The
tumour mass was weighed and minced with
scissors in HBSS. After washing, the cells
were suspended to 6 ml with a cell concentra-
tion of 2-3 x 107 viable cells/ml (50-80%
were trypan-blue-excluding cells). The sus-
pension was layered over a linear sucrose
polymer-diatrizoate density gradient, as de-
scribed for peripheral-blood lymphocytes.
Three bands of cells formed below the inter-
phase, only the lowest band containing lym-
phocytes; this was removed and washed in
HBSS. This separation technique recovered
49-5 + 6 9%oftheviablelymphocytesfromthe
original tumour cell suspension, 54-9+5.0%
of the recovered cells being lymphocytes.
Cytocentrifuge smears were made of the cell
suspension before and after the gradient
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separation and stained with Giemsa. Mono-
cyte macrophages were identified by latex-
bead phagocytosis in both the primary and
separated cell suspensions.
Identification of lymphocyte populations.-
The T and B lymphocytes were identified by
fluorescent antibody (FA) assays as described
by Chandler & Yang (1981). Briefly, B
lymphocytes were identified by direct FA
assay of surface membrane immunoglobulin
(SJg) with fluorescein isothiocyanate (FITC)-
conjugated rabbit anti-dog IgG serum (heavy-
and light-chain-specific; Cappel Laboratories,
Cochranville, Pa). The method used does not
detect monocytes with cytophilically acquired
SIgs. T lymphocytes were identified by an
indirect FA technique. The isolated lympho-
cytes were first incubated with rabbit anti-
dog thymocyte serum prepared in this labora-
tory. After washing, the cells were treated
with FITC-conjugated goat anti-rabbit TgG
serum (heavy- and light-chain-specific; Cap-
pel). For both assays, 200 fluorescing and
non-fluorescing lymphocytes were examined
with an AO fluorescent microscope (Model
2071M, American Optical, Buffalo, N.Y.) and
the percentage offluorescent cells determined.
Double negative cells were recorded as null
cells.
Statistical analysis.-The data obtained
were evaluated by a one-way analysis of
variance or t test, depending on the appro-
priateness of the evaluation.
RESULTS
Classification of tumour
Forty-four dogs andtheir CTVStumours
were classified at the time of killing into
one of the 3 categories described in
Materials and Methods. Twenty-three
dogs had regressing tumours which ranged
in weight from 1P8 to 29-4 g; these dogs
consisted of 9 M and 5 F beagles, 3 M and
5 F collies, and 1 F Labrador-collie
crossbred. Eleven dogs had progressing
tumours, which ranged in weight from
113-0 to 3086 g; these dogs consisted of
3 M and 5 F beagles, 2 F collies and 1 F
Labrador-collie crossbred. Ten dogs had
steady-state tumours which ranged in
weight from 50-4 to 95-9 g; these dogs
consisted of 5 M and 1 F beagles, 1 M and
2 F collies, and 1 F Labrador-collie
crossbred.
Peripheral-blood leucocyte counts
Table I shows the mean percentage and
absolute counts of the peripheral blood
leucocytes of the 13 normal (control)
beagles and the 3 groups of tumour-bear-
ing dogs. Basophils were rarely seen and
hence were not included in this analysis.
There were no statistically significant
differences between the beagles, collie
dogs, and Labrador-collie crossbreds with-
in each group of tumour-bearing dogs, so
their data were grouped together. Analysis
of variance revealed that all groups of
tumour-bearing dogs had significantly
reduced percentages (P < 0.05) and abso-
lute (P < 0.05) counts oflymphocytes when
compared to the normal dogs. The mean
percentages were 33 6 + 0.4% for the
normal dogs and 28-7 + 2.2%, 22-5 + 2.8%,
and 28*2 + 2.0% for the regressor, pro-
gressor, and steady-state tumour dogs
respectively. The mean absolute counts
of lymphocytes for the normal dogs were
4 52 +020x 103/1l and 3 36 +0 26,u,
3-24 + 0-46 ,ul, and 3-49 + 0 33 x lO3/pl for
the regressor, progressor, and steady-state
dogs respectively. In contrast, there were
no significant differences between the
normal and tumour dogs for the total
leucocyte, and for percentages and abso-
lute counts ofneutrophils, monocytes, and
TABLE II.-Percentages and absolute counts (mean+ s.e.) of B, T, and null lymphocytes
in the peripheral blood of the dogs with CTVS at different stages of growth
Tumour
status
(No.)
Normal (12)
Regressor (23)
Progressor (11)
Steady state (10)
35
STg+ cells
( ) ( x 102/111)
17-6 + 1 0 7-15 + 0-67
17-6 + 1-4 6-19 + 0-71
14-8 +2-5 4-75 + 0-96
17-3 + 3-8 4-43 + 1-07
T Cells
I - (%) (x 103/1d)
74-7 +0-7 3-15 + 0-15
73-1 + 2-2 2-83 + 0-43
74-4 + 3-1 2-35 + 0-78
77 0 + 2-8 2-88 + 0 34
Null cells
(%) (x102/j1)
7-6+ 0-9 3 07+ 0-38
9 0+1-9 3-17+0 77
11-3 + 1-7 4-34+ 0-72
9-6+3-1 2-66+0-87
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eosinophils. Although the progressor and
steady-state dogs had higher percentages
and absolute monocyte counts than the
normal dogs, the variation within each
group was quite large and differences were
not statistically significant.
Peripheral-blood lymphocyte subpopulations
The specificity of the immunofluores-
cence reagents was determined by the
method described by Holden et al. (1976)
and Wood & Neff (1978). Lymphocytes,
incubated at 37°C overnight in Ig-free
medium, washed x 6, incubatedwith heat-
inactivated IgG for 1 h at 40C, and incu-
bated at 4°C for 45 min with FITC-
conjugated rabbit anti-dog IgM serum,
did not appreciably alter the percentage
of SIg+ cells reported below, indicating
that the method used does not detect
monocytes with cytophilically acquired
SIgs. The rabbit anti-dog thymocyte
serum has been shown in a previous study
(Chandler & Yang, 1981) to be T-cell-
specific and, through the use of FITC-
conjugated goat anti-rabbit Ig (Alexander
& Sanders, 1977), it was felt that the T-
lymphocyte population was properly de-
fined.
As shown in Table II, no significant
differences in the percentages and absolute
counts ofB, T, and null lymphocytes were
demonstrable, though the absolute counts
of B cells for the progressor and steady-
state dogs (4.75 + 0'96 and 4-43 + 1-07 x
102/pl respectively) were lower than
for normal dogs (7.15 + 0-67 x 102/ikl). The
T- and B-cell absolute counts in general
were lower for the tumour-bearing dogs,
owing to the overall reduction of lympho-
cytes in these dogs (Table I).
Draining lymph-node lymphocyte
subpopulation
The percentages ofSIg+, T-cell-antigen-
positive, and null cells of 5 normal (2 M
and 1 F collies and 1 M and 1 F beagle)
and the 3 groups oftumour dogs are shown
in Table III. The percentage of B cells
TABLE III.-Percentages of B, T, and null
lymphocytes (mean + s.e.) in the draining
lymph nodes of dogs with CTVS at
different stages of growth
Tumour status
(No. studied)
Normal (5)
Regressor (12)
Progressor (5)
Steady state (5)
Cells positive for
A
SIg+ T antigen
16-1+3-1* 68-2 + 3-7
19-1+1-7* 74-2+2-1
8-2+2-3 78-0+19
15-8+ 2-6* 75-1 + 1-6
Null
13-8+5-8
6-9 + 1-3
13-8+ 2-0
9-2+ 3-4
* P < 0-025 for progressors V8 rest.
from the draining lymph nodes of dogs
with progressively growing tumours (8.2 +
2.3%) was significantly lower (P < 0.025)
than in the normal, regressor, and steady-
state tumour dogs (16.1 + 3-1/, 19.1 +
1.7%, and 15X8 + 2-6% respectively). In
contrast, the percentages of T cells did
not significantly differ among the groups
of dogs studied. The null-cell count in the
regressor dogs was lowest (6.9 + 1.3%)
among the groups of dogs examined,
though not significantly so. Absolute
numbers of the lymphocyte subpopula-
tions in the lymph node were determined.
Differential cell count of the tumour cell
suspension
As shown in Table IV, differential cell
counts of the tumour cell suspension
before density-gradient separation showed
that the regressor dogs had significantly
TABLE IV.-Differential cell counts of the cell suspensions of CTVS at different stages of
growth
Tumour status Tumour
(No.) cell Neutrophil Lymphocyte Monocyte Eosinophil Other
Regressor (23) 72-3 + 3-5* 1-4+003 17.3 + 2-3* 1-4+0 3 0 5 + 0-2 70 + 2-8
Progressor(11) 91-5+1 1 0-8+0-4 3-4+0-5 0-4+0-1 0-2+0-1 3-6+0-7
Steadystate (7) 91-2+1-4 1-3+0 5 3-3+0-6 06+0 3 0 3-6+1-6
* Significantly different (P <0.005) from the other two.
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TABLE V. Percentages of T, B, and null lymphocytes infiltrating into the CTVS at
different stages of growth
Tumour status
(No.)
Regressor (21)
Progressor (10)
Stea(dy state (9)
SIg+
26,1 + 19 P < 0-025 373-9+7 78
:30-9 + 5-8
T-antigen positixel
61-2+26 <0-05 340 + 51 P<005
5()8 8+5 7 P<00005
fewer tumour cells (72.3 + 3*50o, P < 0.005)
than the progressor and steady-state
tumour dogs (915±+101% and 91P2+
1-4%). The regressor dogs, in contrast, had
significantly more lymphocytes (17.3 +
2.3%0, P < 0 005) than the progressor and
steady-state dogs (3.4 + 0-500 and 3-3 +
0.6%). The cells classified as "other" were
morphologically like tumour cells, but did
not have prominent nucleoli, patho-
gnomonic of CTVS. Identification of this
cell type is currently under investigation,
and its significance is unclear. In contrast
to other tumour systems, only 0 4-1 4%
of the cells infiltrating into this tumour
were monocytes.
Subpopulations of lyrphocytes infiltrating
the tumour
As shown in Table V, the percentage of
B cells within the tumours of the pro-
gressor dogs (37 3 + 7.40o) was significantly
higher than in regressor dogs (26.1 + 19%0
P < 0 025). The B-cell count of steady-
state dogs (30.9 + 5.8%) lay between
those of the progressors and regressors
and was not significantly different from
either.
The T-cell count of regressor dogs
(61-2 + 2 6%) was significantly higher than
for progressor dogs (34.0 + 5*10%o P<
0.005). In steady-state dogs the percentage
of infiltrating T cells was 50-8 + 5.700,
which was significantly higher than the
progressors (P < 0.005) and significantly
less than the regressors (P < 0.005). The
null-cell count of progressor dogs (26-0 +
6.9%) was significantly higher than that
of regressor dogs (13.5 + 2-9%, P < 0.025).
The null-cell count of steady-state dogs
was 23.9+ 8.6%, which was not signifi-
cantly different from those of either the
regressor or the progressor dogs. The
absolute number of infiltrating lympho-
cytes was not determined. However,
ratios of the lymphocyte populations
infiltrating regressive and progressive
tumours may reflect the types of immune
responses induced. For example, there
were 1 8 times as many T cells within
regressing tumours as in progressing ones,
and 1-4 times as many B cells within
progressor as in regressor tumours. Pro-
gressor tumours also had 1-9 times more
null-cell infiltration than regressive ones.
The percentages and ratios may indicate
that regressors had more tumour-infiltrat-
ing T cells than progressors, while pro-
gressors had more B and null cells infil-
trating than regressors. Steady-state dogs
had intermediate values for all 3 lympho-
cyte populations.
DISCUSSION
In the present study we found a
parallel increase of LM cells infiltrating
regressing tumours, which may be respon-
sible, in part or in whole, for the reduced
tumour size. Most infiltrating LM cells
were lymphocytes. Monocyte-macrophages
infiltrating into the tumour were identified
by latex-bead phagocytosis and cell smears
from primary cell suspensions, and the
percentage of cells was found to be ex-
tremely small (Table IV). Staining of the
glass dishes used to mince the tumours
did not reveal adherent cells, which could
have altered the percentage of macro-
phages, as reported. Thus most host cells
in these tumours really were lymphocytes.
It is felt that monocyte-macrophages do
not play a major role in the immune
response to this tumour, as reported by
others (Korn et al., 1978; Svennevig et al.,
1979).
Null
13 5+2 9 }p<0-025 2 +69 f
23-9 + 8-6
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Further analyses of the subpopulations
oftheinfiltrating lymphocytesshowedthat
the regressing tumours had higher per-
centages of T cells than progressive
tumours, and that B cells, and possibly
null cells, were more prevalent in pro-
gressive tumours. The functional role of
individual lymphocyte subpopulations and
their combinations in progressive tumour
growth and spontaneous regression need
to be established by functional studies of
these lymphocytes. However, it would
appear that T cells are the ones which
contribute most significantly to the rejec-
tion of the tumour. It has been demon-
strated that T cells are responsible for
allograft rejection (Emerson, 1978) and
regression ofthe Moloney sarcoma (Russell
et al., 1976).
In contrast, the prevalence of B cells in
progressive tumours may underscore their
role in tumourgrowth. Forexample, Wood
& Neff (1978) suggested that there was an
altered B-cell pattern in the presence of
malignant neoplasms. This altered flow of
B cells may also have been present in the
dogs which had just received the tumour
transplant and those which did not
undergo rejection. Indeed, we have ob-
served that the draining lymph nodes of
dogs with progressively growing tumours
had significantly lower percentages of
B cells. Whether this tumour in its early
stages of growth is chemo-attractive to
B cells remains to be determined.
The significance of the null-cell popula-
tion infiltrating the tumour is not known.
Their identification was based on the
absence of markers under study, and their
number was lowest of all the cell types.
However, it is of interest to note that the
null-cell population fluctuated, and did
not appear to parallel that of the B and
T cells in the peripheral blood. All the
CTVS-bearing dogs experienced a moder-
ate lymphopenia, in which total T and B
cells remained at a relatively constant
level. The null-cell fluctuation may thus
represent a reserve role in replenishing
certain lymphocyte subpopulations.
Although absolute numbers of lympho-
cyte populations have not been deter-
mined, the ratios of the lymphocyte
populations in the tumour and draining
lymph nodes do reflect the presence of
different immune responses induced by
tumours at different states ofgrowth.
These findings may suggest that B cells
are preferentially attracted to progres-
sively growing tumours and/or are stimu-
latory to tumours. Since there were more
T cells in regressors and B cells in pro-
gressors, the presence of more null cells
in the progressors suggests also that the
differentiation pathway of null cells may
hold the key to the fate of the tumour.
However, changes in the populations of
lymphocytes in the peripheral lymphoid
tissues do not necessarily define the
response of dogs to this tumour.
Although the present findings ofchanges
in lymphocyte subpopulations may or may
not be tumour-specific, our functional
studies (e.g. leucocyte adherence inhibition
(LAI) test (Harding & Yang, 1981)) with
tumour-associated antigen (Palker& Yang,
1981) and normal tissue alloantigens,
suggest that most of the changes are
tumour-specific. Evaluation of the func-
tional capacity of lymphocytes from dogs
with progressive and regressive tumours
is described in a subsequent paper.
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